Literature DB >> 30407465

[Enfermedad de Chagas en México].

Julieta Rojo-Medina1, Cuitláhuac Ruiz-Matus2, Paz María Salazar-Schettino3, Jesús Felipe González-Roldán4.   

Abstract

Chagas disease, which is caused by Trypanosoma cruzi, is considered to be the most serious parasitic disease in America. It is transmitted mainly by triatominae ("kissing bugs"). Mazzoti reported the first two human cases in Mexico. The form of transmission is by parasites entering the organism in feces of the insect, by blood transfusion, from mother to child, by organ transplant and laboratory accidents. In Mexico, 1.1 million people are estimated to be infected; the incidence in 2012 was 0.70 per 1,00,000 population. In 2017, the highest incidence rates were registered in Yucatán, Oaxaca and Hidalgo. The infection causes cardiomyopathies and mega-organs of the digestive tract. Diagnosis in the acute phase is by parasitological approach and, in the chronic phase, by laboratory screening studies. In Mexico's blood banks, screening for Chagas disease is mandatory; from 2007 to 2016, seroprevalence has decreased from 0.40 to 0.32 due to the improvement of donor selection processes and the ad hoc questionnaire. The targets of the parasite are neurons and smooth and myocardial muscle cells. The association of neuronal and smooth muscle destruction defines the presentation of chagas mega-syndromes. Initial manifestations of the disease can go unnoticed; 5% show apparent signs and symptoms and 30% will progress to the chronic asymptomatic phase. Currently available treatments have effect in the acute phase. For the control of Chagas disease, the Specific Action Program for the Prevention and Control of Chagas Disease (PAE Chagas 2013-2018) is available to initiate activities aimed at eliminating transfusion and congenital transmission and controlling vector transmission. The success of medical care depends on oportune detection, early etiological treatment and coverage broadening. On the other hand, monitoring and screening of pregnant women living in risk areas and blood and organ donors universal screening will enable the elimination congenital and transfusion transmission. Copyright:
© 2018 SecretarÍa de Salud.

Entities:  

Keywords:  Chagas disease; Enfermedad de Chagas; Triatominae; Triatominos; Trypanosoma cruzi

Mesh:

Year:  2018        PMID: 30407465     DOI: 10.24875/GMM.18004515

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  7 in total

1.  Consensus Enolase of Trypanosoma Cruzi: Evaluation of Their Immunogenic Properties Using a Bioinformatics Approach.

Authors:  Alejandro Diaz-Hernandez; Maria Cristina Gonzalez-Vazquez; Minerva Arce-Fonseca; Olivia Rodríguez-Morales; Maria Lilia Cedillo-Ramirez; Alejandro Carabarin-Lima
Journal:  Life (Basel)       Date:  2022-05-18

2.  Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission.

Authors:  Antonieta Rojas de Arias; Carlota Monroy; Felipe Guhl; Sergio Sosa-Estani; Walter Souza Santos; Fernando Abad-Franch
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-07-06       Impact factor: 2.747

3.  Review of American Trypanosomiasis in Southern Mexico Highlights Opportunity for Surveillance Research to Advance Control Through the One Health Approach.

Authors:  Doireyner Daniel Velázquez-Ramírez; Adalberto A Pérez de Léon; Héctor Ochoa-Díaz-López
Journal:  Front Public Health       Date:  2022-03-15

4.  Prevalence of Chagas heart disease in dilated cardiomyopathy.

Authors:  Héctor González-Zambrano; Gerardo Amaya-Tapia; María C Franco-Ramos; Oscar J López León-Murguía
Journal:  Arch Cardiol Mex       Date:  2020-10-20

5.  Dietary, Cultural, and Pathogens-Related Selective Pressures Shaped Differential Adaptive Evolution among Native Mexican Populations.

Authors:  Claudia Ojeda-Granados; Paolo Abondio; Alice Setti; Stefania Sarno; Guido Alberto Gnecchi-Ruscone; Eduardo González-Orozco; Sara De Fanti; Andres Jiménez-Kaufmann; Héctor Rangel-Villalobos; Andrés Moreno-Estrada; Marco Sazzini
Journal:  Mol Biol Evol       Date:  2022-01-07       Impact factor: 16.240

Review 6.  Risk of COVID-19 in Chagas Disease Patients: What Happen with Cardiac Affectations?

Authors:  Alejandro Diaz-Hernandez; Maria Cristina Gonzalez-Vazquez; Minerva Arce-Fonseca; Olivia Rodriguez-Morales; Maria Lilia Cedilllo-Ramirez; Alejandro Carabarin-Lima
Journal:  Biology (Basel)       Date:  2021-05-06

7.  Chagas Disease in Pregnant Women from Endemic Regions Attending the Hospital General de Mexico, Mexico City.

Authors:  Indira Chakravarti; Monica Miranda-Schaeubinger; Adriana Ruiz-Remigio; Carlos Briones-Garduño; Edith A Fernández-Figueroa; Concepción Celeste Villanueva-Cabello; Alejandra Borge-Villareal; Yadira Bejar-Ramírez; Alejandro Pérez-González; César Rivera-Benitez; Eyal Oren; Heidi E Brown; Ingeborg Becker; Robert H Gilman
Journal:  Trop Med Infect Dis       Date:  2022-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.